NRSN
Neurosense Therapeutics Ltd
NASDAQ: NRSN · HEALTHCARE · BIOTECHNOLOGY
$0.80
-0.72% today
Updated 2026-04-29
Market cap
$26.53M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.44
Dividend yield
—
52W range
$1 – $3
Volume
0.2M
Neurosense Therapeutics Ltd (NRSN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-2,175.00%
ROA
-247.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-1.23M | — | — | — |
| 2020 | $0.00 | $-2.83M | — | — | — |
| 2021 | $0.00 | $-4.04M | — | — | — |
| 2022 | $0.00 | $-12.34M | — | — | — |
| 2023 | $0.00 | $-10.11M | — | — | — |
| 2024 | $0.00 | $-10.21M | — | — | — |
| 2025 | $0.00 | $-11.13M | — | — | — |